Vitro Biopharma announced receipt of provisional approval from the National Stem Cell Ethics Committee (NSCEC) of the Ministry of Health of the Commonwealth of the Bahamas for a clinical trial entitled “Vitro Biopharma Allogeneic Mesenchymal Stem Cell Therapy For Musculoskeletal Conditions.
2018 Saw accelerated understanding of the roles of stem cells in health and disease. The Shruti Naik lab at the Rockefeller University Howard Hughes Institute demonstrated close interrelationship between immune cells and stem cells. Stem cells store memories of prior activation by stress through specific epigenetic modulation.
Vitro Biopharma (“Vitro”) one of the world’s emerging biotechnology companies focused on Umbilical Cord Mesenchymal Stem Cell (“MSC's”) research and clinical products has been awarded Certification to the International Organization for Standard Quality Control Procedures.